FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

InvaTech Pharma Solutions Levocetirizine Dihydrochloride Tablets Recall

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distribute…

InvaTech Pharma Solutions, LLC · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Dec 9, 2020
Recall ID
D-0115-2021
Check your lot numberHow we source this data

Summary

InvaTech Pharma Solutions recalled Levocetirizine Dihydrochloride Tablets starting Nov 11, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0115-2021 on Dec 9, 2020. Reason: Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.

Product description

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30

Lot numbers, UPCs & expiration codes

Lot #: 051944A Exp. Date April - 2021; 1119124 Exp Date Oct - 2021; 062088 Exp Date June - 2022;

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0115-2021
Classification
Class III
Status
Terminated
Recall initiated
Nov 11, 2020
FDA report date
Dec 9, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
InvaTech Pharma Solutions, LLC

Original FDA data

Every field from FDA enforcement report D-0115-2021, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
86708
Address
40c Cotters Ln Ste A
Code information
Lot #: 051944A Exp. Date April - 2021; 1119124 Exp Date Oct - 2021; 062088 Exp Date June - 2022;
Postal code
08816-2037
Report date
Dec 9, 2020
Product type
Drugs
Recall number
D-0115-2021
Classification
Class III
Recalling firm
InvaTech Pharma Solutions, LLC
Termination date
Jun 20, 2023
Reason for recall
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Nov 11, 2020
Initial firm notification
Letter
Center classification date
Dec 3, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0115-2021, published Dec 9, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls